Document is current
Any future updates will be listed below
-
Authors
Schuermans, Art https://orcid.org/0000-0001-8146-9692
Honigberg, Michael C. https://orcid.org/0000-0001-8630-5021
- License Information
-
More Information
Article History
Accepted: 17 March 2025
First Online: 2 April 2025
Competing interests
: M.C.H. reports consulting fees from Comanche Biopharma, advisory board service for Miga Health, is a site principal investigator for Novartis and has received grant support from Genentech. A.S. declares no competing interests.
